Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Yiran Biotechnology is a prominent Chinese biotechnology company dedicated to the research, development, and industrialization of probiotic microorganisms. The company maintains an extensive biobank of functional strains and operates advanced facilities for high-density fermentation and freeze-drying. Yiran Bio provides a wide range of products including high-activity probiotic powders, fermented starters, and finished health supplements for the pharmaceutical and food industries. Their business model encompasses both proprietary brand development and contract manufacturing (CMO/CDMO) services for global healthcare partners. By focusing on the gut-brain and gut-immune axes, the company aims to provide evidence-based microbial solutions for digestive and metabolic health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Yiran Biotechnology.